MUC1 and neoplasm: MUC1 interacts with TLR and NLRP3 inflammasome pathways: while it can initially suppress excessive inflammation by competitively inhibiting MyD88/TRIF recruitment to TLRs, sustained interactions with microbes may exacerbate pro-inflammatory responses, ultimately fostering a tumor-promoting microenvironment (28, 29).